|
|
||||||||
Journal of General Virology, Vol 80, 907-916, Copyright © 1999 by Society for General Microbiology
ARTICLES |
MN Mulders, JH Reimerink, M Stenvik, I Alaeddinoglu, HG van der Avoort, T Hovi and MP Koopmans
Enterovirus Laboratory, Department of Virology, National Public Health Institute (KTL), Helsinki, Finland. Mick.Mulders@ktl.fi
Poliovirus strains derived from the oral poliovirus vaccine (Sabin) can be differentiated from wild-type poliovirus by tests based on either immunological or genetic properties of the strains. The characterization of a recently identified poliovirus type 1 isolate with exceptional properties is described. Initial phenotypic analysis of the virus by use of polyclonal absorbed antisera suggested a wild- type character. However, the different genomic analyses all confirmed the Sabin-derived character of the virus. All 17 plaques isolated from the strain shared these properties, thus excluding the possibility of a mixture of a wild-type and a Sabin-derived strain. To elucidate the properties of this virus further, the nucleotide sequences of the P1 region and most of the 5' non-coding region were established. Although the nucleotide identity with Sabin 1 was more than 99.4%, mutations were observed in regions encoding three major antigenic sites; the deduced amino acid substitutions confirmed the aberrant results of micro-neutralization assays with site-specific monoclonal antibodies. The most striking feature was the existence of a hexanucleotide deletion in the VP1 gene, which gave rise to a two amino acid deletion in the BC loop. In spite of these antigenic changes, the strain was readily serotyped as poliovirus type 1 under standard conditions. Likewise, replication of the virus under cell culture conditions was not affected by these mutations or by the deletion. Standard polio vaccination protects against this aberrant virus, and its epidemiological significance remains open.
This article has been cited by other articles:
![]() |
J. K. Odoom, Z. Yunus, G. Dunn, P. D. Minor, and J. Martin Changes in Population Dynamics during Long-Term Evolution of Sabin Type 1 Poliovirus in an Immunodeficient Patient J. Virol., September 15, 2008; 82(18): 9179 - 9190. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Aragones, A. Bosch, and R. M. Pinto Hepatitis A Virus Mutant Spectra under the Selective Pressure of Monoclonal Antibodies: Codon Usage Constraints Limit Capsid Variability J. Virol., February 15, 2008; 82(4): 1688 - 1700. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Dedepsidis, Z. Kyriakopoulou, V. Pliaka, C. Kottaridi, E. Bolanaki, S. Levidiotou-Stefanou, D. Komiotis, and P. Markoulatos Retrospective Characterization of a Vaccine-Derived Poliovirus Type 1 Isolate from Sewage in Greece Appl. Envir. Microbiol., November 1, 2007; 73(21): 6697 - 6704. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Kyriakopoulou, C. Kottaridi, E. Dedepsidis, E. Bolanaki, S. Levidiotou-Stefanou, and P. Markoulatos Molecular Characterization of Wild-Type Polioviruses Isolated in Greece during the 1996 Outbreak in Albania. J. Clin. Microbiol., March 1, 2006; 44(3): 1150 - 1152. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Shimizu, B. Thorley, F. J. Paladin, K. A. Brussen, V. Stambos, L. Yuen, A. Utama, Y. Tano, M. Arita, H. Yoshida, et al. Circulation of Type 1 Vaccine-Derived Poliovirus in the Philippines in 2001 J. Virol., December 15, 2004; 78(24): 13512 - 13521. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Hovi, N. Lindholm, C. Savolainen, M. Stenvik, and C. Burns Evolution of wild-type 1 poliovirus in two healthy siblings excreting the virus over a period of 6 months J. Gen. Virol., February 1, 2004; 85(2): 369 - 377. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Blomqvist, A.-L. Bruu, M. Stenvik, and T. Hovi Characterization of a recombinant type 3/type 2 poliovirus isolated from a healthy vaccinee and containing a chimeric capsid protein VP1 J. Gen. Virol., March 1, 2003; 84(3): 573 - 580. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Triki, M. R. Barbouche, O. Bahri, M. Bejaoui, and K. Dellagi Community-Acquired Poliovirus Infection in Children with Primary Immunodeficiencies in Tunisia J. Clin. Microbiol., March 1, 2003; 41(3): 1203 - 1211. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Cherkasova, E. A. Korotkova, M. L. Yakovenko, O. E. Ivanova, T. P. Eremeeva, K. M. Chumakov, and V. I. Agol Long-Term Circulation of Vaccine-Derived Poliovirus That Causes Paralytic Disease J. Virol., June 5, 2002; 76(13): 6791 - 6799. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Horie, H. Yoshida, K. Matsuura, M. Miyazawa, Y. Ota, T. Nakayama, Y. Doi, and S. Hashizume Neurovirulence of Type 1 Polioviruses Isolated from Sewage in Japan Appl. Envir. Microbiol., January 1, 2002; 68(1): 138 - 142. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Georgopoulou, P. Markoulatos, N. Spyrou, and N. C. Vamvakopoulos Improved Genotyping Vaccine and Wild-Type Poliovirus Strains by Restriction Fragment Length Polymorphism Analysis: Clinical Diagnostic Implications J. Clin. Microbiol., December 1, 2000; 38(12): 4337 - 4342. [Abstract] [Full Text] |
||||
![]() |
K. Matsuura, M. Ishikura, H. Yoshida, T. Nakayama, S. Hasegawa, S. Ando, H. Horie, T. Miyamura, and T. Kitamura Assessment of Poliovirus Eradication in Japan: Genomic Analysis of Polioviruses Isolated from River Water and Sewage in Toyama Prefecture Appl. Envir. Microbiol., November 1, 2000; 66(11): 5087 - 5091. [Abstract] [Full Text] |
||||
![]() |
M. N. Mulders, M. Salminen, N. Kalkkinen, and T. Hovi Molecular epidemiology of coxsackievirus B4 and disclosure of the correct VP1/2Apro cleavage site: evidence for high genomic diversity and long-term endemicity of distinct genotypes J. Gen. Virol., March 1, 2000; 81(3): 803 - 812. [Abstract] [Full Text] |
||||
![]() |
T. Herremans, J. H. J. Reimerink, T. G. Kimman, H. G. A. M. van der Avoort, and M. P. G. Koopmans Antibody Responses to Antigenic Sites 1 and 3 of Serotype 3 Poliovirus after Vaccination with Oral Live Attenuated or Inactivated Poliovirus Vaccine and after Natural Exposure Clin. Vaccine Immunol., January 1, 2000; 7(1): 40 - 44. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |